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Introduction
Genome-wide association studies (GWAS) are a novel
and promising method to study genetic susceptibility fac-
tors for common disorders, including migraine.
Objective
Here we performed the first GWAS in migraine without
aura (MO), which is the most common form of migraine.
Methods
To identify common genetic variants for this migraine
type, we analyzed genome-wide association data of 2,326
clinic-based German and Dutch patients and 4,580 popu-
lation-matched controls. Loci with two or more SNPs
with P-values < 1 x 10-5 were selected for follow-up in
2,508 Dutch, Spanish, Finnish and Norwegian patients
and 2,652 controls.
Results
Meta-analysis of the discovery and replication data yielded
four genome-wide significant (P < 5 x 10-8) MO suscept-
ibility loci in or nearby MEF2D, PHACTR1, ASTN2 and
TGFBR2. In addition, SNPs in two loci (in or near TRPM8
and LRP1) that were previously identified in a GWAS on
population-based migraine were significantly replicated in
our clinic-based MO cohort.
Conclusion
This study reveals the first susceptibility loci for migraine
without aura, thereby expanding our knowledge of this
debilitating neurological disorder.
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